The Utility of FDG-PET for Radiation Treatment in NSCLC
The Utility of 18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for Radiation Treatment Planning in Non-Small Cell Lung Cancer (NSCLC)
2 other identifiers
observational
50
1 country
1
Brief Summary
Patients planned for radical radiation for NSCLC will undergo conventional CT stimulation and also PET/CT scans for definition of radiation target volumes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 4, 2006
CompletedFirst Posted
Study publicly available on registry
October 6, 2006
CompletedJuly 25, 2017
August 1, 2011
October 4, 2006
July 21, 2017
Conditions
Keywords
Interventions
Eligibility Criteria
Non-small cell lung cancer
You may qualify if:
- Non-small cell lung cancer to receive radical radiation
You may not qualify if:
- unable to tolerate PET/CT scan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AHS Cancer Control Albertalead
- Calgary Health Regioncollaborator
Study Sites (1)
Tom Baker Cancer Centre
Calgary, Alberta, T2N 4N2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harold P Lau, MD
AHS Cancer Control Alberta
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2006
First Posted
October 6, 2006
Study Start
October 1, 2006
Last Updated
July 25, 2017
Record last verified: 2011-08